Related Experiment Videos
HLA B27 negative ankylosing spondylitis--a rare condition.
Australian and New Zealand Journal of Medicine
|April 1, 1980
Summary
New criteria suggest HLA B27 negative ankylosing spondylitis is rarer than previously believed. This study examines two cases meeting these strict definitions and discusses their implications for future research.
Area of Science:
- Rheumatology and Immunology
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease.
- Human Leukocyte Antigen B27 (HLA B27) is a genetic marker associated with AS.
- The prevalence of HLA B27 negative AS requires clarification.
Observation:
- Two cases of ankylosing spondylitis were identified that strictly adhere to recently proposed diagnostic criteria.
- These cases were negative for the HLA B27 genetic marker.
- Family studies were conducted to investigate genetic and environmental factors.
Findings:
- The application of new, stringent criteria indicates that HLA B27 negative ankylosing spondylitis is less prevalent than previously estimated.
- The presented cases fulfill these updated diagnostic standards for non-HLA B27 associated AS.
- Family data provided insights into the inheritance patterns and familial aggregation.
Implications:
- Revised diagnostic criteria necessitate a re-evaluation of the epidemiology of HLA B27 negative ankylosing spondylitis.
- Future research on non-HLA B27 AS should adopt these stricter criteria for accurate case ascertainment.
- Understanding the distinct characteristics of HLA B27 negative AS may lead to targeted therapeutic strategies.